Across TCGA pan-cancer cohorts, LINC02185 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated LINC02185 data layer.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher LINC02185 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02185 expression acts as an unfavorable survival marker, although some lineages such as SKCM and ACC show a favorable association.
UCEC, SKCM, and ACC are the cancer types where LINC02185 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.